SCM
DGX icon

Symons Capital Management’s Quest Diagnostics DGX Stock Holding History

Symons Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40,180
Closed -$3.23M – 84
2020
Q1 		$3.23M Sell
40,180
-1,666
-4% -$172K 1.89% 21
2019
Q4 		$4.47M Sell
41,846
-12,282
-23% -$1.28M 2.32% 20
2019
Q3 		$5.79M Sell
54,128
-5,461
-9% -$561K 2.67% 16
2019
Q2 		$6.07M Sell
59,589
-2,609
-4% -$251K 2.52% 16
2019
Q1 		$5.59M Buy
+62,198
New +$5.39M 2.41% 22

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Symons Capital Management's DGX Position: Q2 2020 in Review

Symons Capital Management sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 40,180 shares — an estimated $3.23M sold.

Symons Capital Management first reported a position in DGX in Q1 2019 and held it in 5 quarters. The position peaked at $6.07M in Q2 2019. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • Symons Capital Management reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Symons Capital Management sold 40,180 Quest Diagnostics shares in Q2 2020, an estimated $3.23M.
  • Symons Capital Management first reported a position in Quest Diagnostics in Q1 2019 and held it in 5 quarters.
  • Symons Capital Management's Quest Diagnostics position peaked at $6.07M in Q2 2019.
  • 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Symons Capital Management's 13F filing for Q2 2020, filed 31 Jul 2020.